According to what I read, what this company does is first of a kind, direct-to-consumer DNA analysis using the most powerful AI that measures 60 million genomic data points to precisely predict risk for developing diseases such as most cancers, diabetes, rheumatoid arthritis, and Crohn's Disease, as well as nutritional deficiencies that lead to disease.
This is interesting to me and I see here something of the future to individualizing medicine and the next important step in medicine. Now folks like me see the way traditional medicine being non individual in many ways and medicine dispensed merely on groups, age, and sex. That is not enough and a lot has to change in dispensing what kind of medicine, what dosage after knowing scientifically what happens to be one's DNA and the impact of one's specific unknown information. I have seen and suffered and finally rejected traditional medical imprecise approaches and the future of medicine will have to be based directly on one's specific DNA analysis and not general knowledge from large multitudes of people's data.
If all that I read is true, this company is an "avant-garde" of a better and brighter future. I intend to buy 1000 shares at the current price of $0.88, this Monday June 17, 2019.
The article's projected 12-28 month prices: S.T. (12 months) is $4.24;
M.T. (24 months) is $10.47; and L.T. (28 months) is $23.41
Nobody knows the future, let alone this company and it's future. I happen to be excited by such news and happy to spend this money, and more, in AI and Biotech endeavor and basically about these industries and the promises they hold in the health area. I happen to be also a gamer and (high?) risk taker. Been a high roller before my retirement and still enjoy being one! GLTA
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM